ONLINE DATABASE SEARCH - HIV-LS-302-MEMO
1. 43847 HIV-LS-302; PUBMED-HIV-8/10/2004
Inhibitory Effects of Some Traditional Medicines on Proliferation of HIV-1 and Its Protease
Nakamura, N
Yakugaku Zasshi 2004. 124(8): 519-29
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15297721&dopt=abstract
2. 43848 HIV-LS-302; PUBMED-HIV-8/10/2004
Metabolites produced by actinomycetes -antiviral antibiotics and enzyme inhibitors-
Uyeda, M
Yakugaku Zasshi 2004. 124(8): 469-79
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15297717&dopt=abstract
3. 43849 HIV-LS-302; EMBASE-HIV-8/10/2004
Primer unblocking by HIV-1 reverse transcriptase and resistance to nucleoside RT inhibitors (NRTIs)
Goldschmidt, Valerie and Marquet, Roland
The International Journal of Biochemistry & Cell Biology 2004. 36(9): 1687-1705
HYPERLINK: http://www.sciencedirect.com/science/article/B6TCH-4CBVS67-5/2/9c6a6ada8af67fe7c343416e7211f9f4
4. 43850 HIV-LS-302; PUBMED-HIV-8/10/2004
Screening assay for the identification of deoxyhypusine synthase inhibitors
Sommer, MN, Bevec, D, Klebl, B, Flicke, B, Holscher, K, Freudenreich, T, Hauber, I, Hauber, J, and Mett, H
J Biomol Screen 2004. 9(5): 434-8
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15296643&dopt=abstract
5. 43851 HIV-LS-302; EMBASE-HIV-8/10/2004
Nucleoside-analog resistance mutations in HIV-1 reverse transcriptase and their influence on polymerase fidelity and viral mutation rates
Rezende, Lisa F and Prasad, Vinayaka R
The International Journal of Biochemistry & Cell Biology 2004. 36(9): 1716-1734
HYPERLINK: http://www.sciencedirect.com/science/article/B6TCH-4CCNSCT-1/2/938ce7ca91fb2f824fbcae862b6182ac
6. 43852 HIV-LS-302; PUBMED-HIV-8/10/2004
Inhibitor design by wrapping packing defects in HIV-1 proteins
Fernandez, A, Rogale, K, Scott, R, and Scheraga, HA
Proc Natl Acad Sci U S A 2004
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15289598&dopt=abstract
7. 43853 HIV-LS-302; EMBASE-HIV-8/10/2004
Concerted inhibitory activities of Phyllanthus amarus on HIV replication in vitro and ex vivo
Notka, Frank, Meier, Georg, and Wagner, Ralf
Antiviral Research 2004. In Press, Uncorrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6T2H-4D1MTW2-1/2/056d693b4ebe293c9df208555d351151
8. 43854 HIV-LS-302; PUBMED-HIV-8/10/2004
Phenotypic impact of HIV reverse transcriptase M184I/V mutations in combination with single thymidine analog mutations on nucleoside reverse transcriptase inhibitor resistance
Ross, L, Parkin, N, Chappey, C, Fisher, R, Clair, MS, Bates, M, Tisdale, M, and Lanier, ER
AIDS 2004. 18(12): 1691-6
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15280780&dopt=abstract
9. 43855 HIV-LS-302; PUBMED-HIV-8/10/2004
Antiretroviral drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase increase template-switching frequency
Nikolenko, GN, Svarovskaia, ES, Delviks, KA, and Pathak, VK
J Virol 2004. 78(16): 8761-70
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15280484&dopt=abstract
10. 43856 HIV-LS-302; PUBMED-HIV-8/10/2004
Spirodiketopiperazine-Based CCR5 Inhibitor Which Preserves CC-Chemokine/CCR5 Interactions and Exerts Potent Activity against R5 Human Immunodeficiency Virus Type 1 In Vitro
Maeda, K, Nakata, H, Koh, Y, Miyakawa, T, Ogata, H, Takaoka, Y, Shibayama, S, Sagawa, K, Fukushima, D, Moravek, J, Koyanagi, Y, and Mitsuya, H
J Virol 2004. 78(16): 8654-62
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15280474&dopt=abstract
11. 43857 HIV-LS-302; PUBMED-HIV-8/10/2004
Initial Cleavage of the Human Immunodeficiency Virus Type 1 GagPol Precursor by Its Activated Protease Occurs by an Intramolecular Mechanism
Pettit, SC, Everitt, LE, Choudhury, S, Dunn, BM, and Kaplan, AH
J Virol 2004. 78(16): 8477-85
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15280456&dopt=abstract
12. 43858 HIV-LS-302; PUBMED-HIV-8/10/2004
The challenge of antiretroviral-drug-resistant HIV: is there any possible clinical advantage?
Zaccarelli, M, Tozzi, V, Perno, CF, and Antinori, A
Curr HIV Res 2004. 2(3): 283-92
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15279592&dopt=abstract
13. 43859 HIV-LS-302; PUBMED-HIV-8/10/2004
From the Cover: A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase
Hazuda, DJ, Anthony, NJ, Gomez, RP, Jolly, SM, Wai, JS, Zhuang, L, Fisher, TE, Embrey, M, Guare, JP Jr, Egbertson, MS, Vacca, JP, Huff, JR, Felock, PJ, Witmer, MV, Stillmock, KA, Danovich, R, Grobler, J, Miller, MD, Espeseth, AS, Jin, L, Chen, IW, Lin, JH, Kassahun, K, Ellis, JD, Wong, BK, Xu, W, Pearson, PG, Schleif, WA, Cortese, R, Emini, E, Summa, V, Holloway, MK, and Young, SD
Proc Natl Acad Sci U S A 2004. 101(31): 11233-8
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15277684&dopt=abstract
14. 43860 HIV-LS-302; EMBASE-HIV-8/10/2004
A polymeric immunoglobulin receptor-like milk protein with inhibitory activity on human immunodeficiency virus type 1 reverse transcriptase
Ng, TB and Ye, XY
The International Journal of Biochemistry & Cell Biology 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6TCH-4CVX2KS-1/2/958ddeb20d03be20e2a5378cbb8b08db
15. 43861 HIV-LS-302; PUBMED-HIV-8/10/2004
Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome (AIDS) drug candidate, targeting CD4 in lymphocytes
Miao, B, Geng, M, Li, J, Li, F, Chen, H, Guan, H, and Ding, J
Biochem Pharmacol 2004. 68(4): 641-9
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15276071&dopt=abstract
16. 43862 HIV-LS-302; PUBMED-HIV-8/10/2004
Zidovudine, lamivudine, and abacavir have different effects on resting cells infected with human immunodeficiency virus in vitro
Saavedra-Lozano, J, McCoig, CC, Cao, Y, Vitetta, ES, and Ramilo, O
Antimicrob Agents Chemother 2004. 48(8): 2825-30
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15273087&dopt=abstract
17. 43863 HIV-LS-302; PUBMED-HIV-8/10/2004
Efficient 3D Database Screening for Novel HIV-1 IN Inhibitors
Barreca, ML, Rao, A, De Luca, L, Zappala, M, Gurnari, C, Monforte, P, De Clercq, E, Van Maele, B, Debyser, Z, Witvrouw, M, Briggs, JM, and Chimirri, A
J Chem Inf Comput Sci 2004. 44(4): 1450-1455
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15272853&dopt=abstract
18. 43864 HIV-LS-302; PUBMED-HIV-8/10/2004
Systemic and mucosal immunity in rhesus macaques immunized with HIV-1 peptide and gp120 conjugated to Brucella abortus
Eller, N, Golding, H, Inoue, S, Beining, P, Inman, J, Matthews, N, Scott, DE, and Golding, B
J Med Primatol 2004. 33(4): 167-174
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15271066&dopt=abstract
19. 43865 HIV-LS-302; EMBASE-HIV-8/10/2004
Impact of frequent natural polymorphisms at the protease gene on the in vitro susceptibility to protease inhibitors in HIV-1 non-B subtypes
Holguin, Africa, Paxinos, Ellen, Hertogs, Kurt, Womac, Chad, and Soriano, Vincent
Journal of Clinical Virology 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6VJV-4CF3C93-1/2/98086dc01c8d6eaf303cd4fcc7c51bc1
20. 43866 HIV-LS-302; PUBMED-HIV-8/10/2004
New Antiretroviral Agents for the Treatment of HIV Infection
Marks, K and Gulick, RM
Curr Infect Dis Rep 2004. 6(4): 333-339
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15265463&dopt=abstract
21. 43867 HIV-LS-302; PUBMED-HIV-8/10/2004
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients
Torti, C, Quiros-Roldan, E, Monno, L, Patroni, A, Saracino, A, Angarano, G, Tinelli, C, Lo, Caputo S, Tirelli, V, Mazzotta, F, and Carosi, G
J Med Virol 2004. 74(1): 29-33
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15258965&dopt=abstract
22. 43868 HIV-LS-302; PUBMED-HIV-8/10/2004
Antiretroviral and immunosuppressive drug-drug interactions: An update
Izzedine, H, Launay-Vacher, V, Baumelou, A, and Deray, G
Kidney Int 2004. 66(2): 532-541
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15253704&dopt=abstract
23. 43869 HIV-LS-302; WOS-HIV-8/2/2004
Tryptophan scanning mutagenesis of aromatic residues within the polymerase domain of HIV-l reverse transcriptase: critical role of Phe-130 for p51 function and second-site revertant restoring viral replication capacity
Olivares, I, Gutierrez-Rivas, M, Lopez-Galindez, C, and Menendez-Arias, L
VIROLOGY 2004. 324(2): 400-411
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222376800014
24. 43870 HIV-LS-302; WOS-HIV-8/2/2004
Preparation and pharmacokinetics of C-11 labeled stavudine (d4T)
Livni, E, Berker, M, Hillier, S, Waller, SC, Ogan, MD, Discordia, RP, Rienhart, JK, Rubin, RH, and Fischman, AJ
NUCL MED BIOL 2004. 31(5): 613-621
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222425900011
25. 43871 HIV-LS-302; WOS-HIV-8/2/2004
Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion
Rawat, SS, Gallo, SA, Eaton, J, Martin, TD, Ablan, S, KewalRamani, VN, Wang, JM, Blumenthal, R, and Puri, A
J VIROL 2004. 78(14): 7360-7368
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222407200008
26. 43872 HIV-LS-302; WOS-HIV-8/2/2004
Determinants of human immunodeficiency virus type 1 baseline susceptibility to the fusion inhibitors enfuvirtide and T-649 reside outside the peptide interaction site
Heil, ML, Decker, JM, Sfakianos, JN, Shaw, GM, Hunter, E, and Derdeyn, CA
J VIROL 2004. 78(14): 7582-7589
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222407200032
27. 43873 HIV-LS-302; WOS-HIV-8/2/2004
Recent advances in the development of next generation non-nucleoside reverse transcriptase inhibitors
Tarby, CM
CURR TOP MED CHEM 2004. 4(10): 1045-1057
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222455200004
28. 43874 HIV-LS-302; WOS-HIV-8/2/2004
Ampelopsin, a small molecule inhibitor of HIV-1 infection targeting HIV entry
Liu, DY, Ye, JT, Yang, WH, Yan, J, Zeng, CH, and Zeng, S
BIOMED ENVIRON SCI 2004. 17(2): 153-164
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222414600004
29. 43875 HIV-LS-302; WOS-HIV-8/2/2004
gp340 (SAG) binds to the V3 sequence of gp120 important for chemokine receptor interaction
Wu, ZW, Golub, E, Abrams, WR, and Malamud, D
AIDS RES HUM RETROV 2004. 20(6): 600-607
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222347000005
30. 43876 HIV-LS-302; WOS-HIV-8/8/2004
Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1
Sayah, DM, Sokolskaja, E, Berthoux, L, and Luban, J
NATURE 2004. 430(6999): 569-573
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222946100050
31. 43877 HIV-LS-302; WOS-HIV-8/8/2004
Camelized rabbit-derived VH single-domain Intrabodies Against vif strongly neutralize HIV-1 infectivity
da Silva, FA, Santa-Marta, M, Freitas-Vieira, A, Mascarenhas, P, Barahona, I, Moniz-Pereira, J, Gabuzda, D, and Goncalves, J
J MOL BIOL 2004. 340(3): 525-542
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222560000011
32. 43878 HIV-LS-302; WOS-HIV-8/8/2004
Initiation of antiretroviral therapy during recent HIV-1 infection results in lower residual viral reservoirs
Pires, A, Hardy, G, Gazzard, B, Gotch, F, and Imami, N
JAIDS-J ACQ IMM DEF 2004. 36(3): 783-790
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222481700003
33. 43879 HIV-LS-302; WOS-HIV-8/8/2004
Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity
Romanelli, F, Smith, KM, and Hoven, AD
CURR PHARM DESIGN 2004. 10(21): 2643-2648
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222539600009
34. 43880 HIV-LS-302; WOS-HIV-8/8/2004
Increased expression of Toll-like receptor 2 on monocytes in HIV infection: Possible roles in inflammation and viral replication
Heggelund, L, Muller, F, Lien, E, Yndestad, A, Ueland, T, Kristiansen, KI, Espevik, T, Aukrust, P, and Froland, SS
CLIN INFECT DIS 2004. 39(2): 264-269
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222474300018
35. 43881 HIV-LS-302; WOS-HIV-8/8/2004
Intracellular expression of antisense RNA. transcripts complementary to the human immunodeficiency virus type-1 vif gene inhibits viral replication in infected T-lymphoblastoid cells
Barnor, JS, Miyano-Kurosaki, N, Yamaguchi, K, Sakamoto, A, Ishikawa, K, Inagaki, Y, Yamamoto, N, Osei-Kwasi, M, Ofori-Adjei, D, and Takaku, H
BIOCHEM BIOPH RES CO 2004. 320(2): 544-550
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222567700040